117 related articles for article (PubMed ID: 1634644)
1. Effect of moricizine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Benedek IH; King SY; Powell RJ; Agra AM; Schary WL; Pieniaszek HJ
J Clin Pharmacol; 1992 Jun; 32(6):558-63. PubMed ID: 1634644
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interactions of moricizine and diltiazem in healthy volunteers.
Shum L; Pieniaszek HJ; Robinson CA; Davidson AF; Widner PJ; Benedek IH; Flamenbaum W
J Clin Pharmacol; 1996 Dec; 36(12):1161-8. PubMed ID: 9013374
[TBL] [Abstract][Full Text] [Related]
3. Enzyme induction by moricizine: time course and extent in healthy subjects.
Benedek IH; Davidson AF; Pieniaszek HJ
J Clin Pharmacol; 1994 Feb; 34(2):167-75. PubMed ID: 8163717
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of moricizine.
Siddoway LA; Schwartz SL; Barbey JT; Woosley RL
Am J Cardiol; 1990 Feb; 65(8):21D-25D; discussion 68D-71D. PubMed ID: 2407090
[TBL] [Abstract][Full Text] [Related]
5. Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin.
Van Hecken A; Verbesselt R; Depré M; Tjandramaga TB; Angehrn J; Cawello W; De Schepper PJ
Eur J Clin Pharmacol; 1993; 45(3):291-3. PubMed ID: 8276058
[TBL] [Abstract][Full Text] [Related]
6. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.
Liao S; Palmer M; Fowler C; Nayak RK
J Clin Pharmacol; 1996 Nov; 36(11):1072-7. PubMed ID: 8973996
[TBL] [Abstract][Full Text] [Related]
7. Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.
Toon S; Holt BL; Mullins FG; Bullingham R; Aarons L; Rowland M
Br J Clin Pharmacol; 1990 Nov; 30(5):743-50. PubMed ID: 2271374
[TBL] [Abstract][Full Text] [Related]
8. Norfloxacin does not alter warfarin's disposition or anticoagulant effect.
Rocci ML; Vlasses PH; Distlerath LM; Gregg MH; Wheeler SC; Zing W; Bjornsson TD
J Clin Pharmacol; 1990 Aug; 30(8):728-32. PubMed ID: 2401751
[TBL] [Abstract][Full Text] [Related]
9. Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.
Apseloff G; Wilner KD; Gerber N
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):29S-33S. PubMed ID: 7547090
[TBL] [Abstract][Full Text] [Related]
10. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.
Trenk D; Möhrke W; Warth L; Jähnchen E
Arzneimittelforschung; 1993 Aug; 43(8):836-41. PubMed ID: 8216438
[TBL] [Abstract][Full Text] [Related]
11. Effect of moricizine on the pharmacokinetics of single-dose theophylline in healthy subjects.
Pieniaszek HJ; Davidson AF; Benedek IH
Ther Drug Monit; 1993 Jun; 15(3):199-203. PubMed ID: 8332999
[TBL] [Abstract][Full Text] [Related]
12. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Zhu M; Chan KW; Ng LS; Chang Q; Chang S; Li RC
J Pharm Pharmacol; 1999 Feb; 51(2):175-80. PubMed ID: 10217316
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of moricizine HCl.
Woosley RL; Morganroth J; Fogoros RN; McMahon FG; Humphries JO; Mason DT; Williams RL
Am J Cardiol; 1987 Oct; 60(11):35F-39F. PubMed ID: 3310583
[TBL] [Abstract][Full Text] [Related]
14. The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Zhi J; Melia AT; Guerciolini R; Koss-Twardy SG; Passe SM; Rakhit A; Sadowski JA
J Clin Pharmacol; 1996 Jul; 36(7):659-66. PubMed ID: 8844450
[TBL] [Abstract][Full Text] [Related]
15. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
[TBL] [Abstract][Full Text] [Related]
16. No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin.
Schall R; Müller FO; Hundt HK; Ritter W; Duursema L; Groenewoud G; Middle MV
J Clin Pharmacol; 1995 Mar; 35(3):306-13. PubMed ID: 7608323
[TBL] [Abstract][Full Text] [Related]
17. Moricizine-warfarin: a possible drug interaction.
Serpa MD; Cossolias J; McGreevy MJ
Ann Pharmacother; 1992 Jan; 26(1):127. PubMed ID: 1606334
[No Abstract] [Full Text] [Related]
18. Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.
Miller JW; Skerjanec A; Knadler MP; Ghosh A; Allerheiligen SR
Pharm Res; 2001 Jul; 18(7):1024-8. PubMed ID: 11496940
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans.
Awni WM; Hussein Z; Granneman GR; Patterson KJ; Dubé LM; Cavanaugh JH
Clin Pharmacokinet; 1995; 29 Suppl 2():67-76. PubMed ID: 8620673
[TBL] [Abstract][Full Text] [Related]
20. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
Niopas I; Toon S; Aarons L; Rowland M
Eur J Clin Pharmacol; 1999 Jul; 55(5):399-404. PubMed ID: 10456491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
